{"id":"https://openalex.org/W2159130241","doi":"https://doi.org/10.1080/03639040701484593","title":"PLGA Nanoparticles for the Oral Delivery of 5-Fluorouracil Using High Pressure Homogenization-Emulsification as the Preparation Method and In Vitro/In Vivo Studies","display_name":"PLGA Nanoparticles for the Oral Delivery of 5-Fluorouracil Using High Pressure Homogenization-Emulsification as the Preparation Method and In Vitro/In Vivo Studies","publication_year":2008,"publication_date":"2008-01-01","ids":{"openalex":"https://openalex.org/W2159130241","doi":"https://doi.org/10.1080/03639040701484593","mag":"2159130241","pmid":"https://pubmed.ncbi.nlm.nih.gov/18214762"},"language":"en","primary_location":{"id":"doi:10.1080/03639040701484593","doi":"https://doi.org/10.1080/03639040701484593","is_oa":false,"landing_page_url":"https://doi.org/10.1080/03639040701484593","pdf_url":null,"source":{"id":"https://openalex.org/S162444473","display_name":"Drug Development and Industrial Pharmacy","issn_l":"0363-9045","issn":["0363-9045","1520-5762"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","medline","norway-1","poland-70","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Drug Development and Industrial Pharmacy","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5100421863","display_name":"Xueming Li","orcid":"https://orcid.org/0000-0001-6081-5592","observed_orcids":["https://orcid.org/0000-0001-6081-5592"]},"institutions":[{"id":"https://openalex.org/I134687103","display_name":"Nanjing Tech University","ror":"https://ror.org/03sd35x91","country_code":"CN","type":"education","lineage":["https://openalex.org/I134687103"]},{"id":"https://openalex.org/I161716053","display_name":"China Pharmaceutical University","ror":"https://ror.org/01sfm2718","country_code":"CN","type":"education","lineage":["https://openalex.org/I161716053"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"XueMing Li","raw_affiliation_strings":["College of Life Science and Pharmaceutics, Nanjing University of Technology, Nanjing, Jiangsu, PR China. xuemingli@njut.edu.cn","College of Life Science and Pharmaceutics, Nanjing University of Technology and China Pharmaceutical University, Nanjing, Jiangsu, P.R. China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"College of Life Science and Pharmaceutics, Nanjing University of Technology, Nanjing, Jiangsu, PR China. xuemingli@njut.edu.cn","institution_ids":["https://openalex.org/I134687103"]},{"raw_affiliation_string":"College of Life Science and Pharmaceutics, Nanjing University of Technology and China Pharmaceutical University, Nanjing, Jiangsu, P.R. China","institution_ids":["https://openalex.org/I134687103","https://openalex.org/I161716053"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5032193824","display_name":"Yuanlong Xu","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I134687103","display_name":"Nanjing Tech University","ror":"https://ror.org/03sd35x91","country_code":"CN","type":"education","lineage":["https://openalex.org/I134687103"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"YuanLong Xu","raw_affiliation_strings":["College of Life Science and Pharmaceutics, Nanjing University of Technology, Nanjing, Jiangsu, P.R. China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"College of Life Science and Pharmaceutics, Nanjing University of Technology, Nanjing, Jiangsu, P.R. China","institution_ids":["https://openalex.org/I134687103"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5063225058","display_name":"Guoguang Chen","orcid":"https://orcid.org/0000-0002-8375-3512","observed_orcids":["https://orcid.org/0000-0002-8375-3512"]},"institutions":[{"id":"https://openalex.org/I134687103","display_name":"Nanjing Tech University","ror":"https://ror.org/03sd35x91","country_code":"CN","type":"education","lineage":["https://openalex.org/I134687103"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"GuoGuang Chen","raw_affiliation_strings":["College of Life Science and Pharmaceutics, Nanjing University of Technology, Nanjing, Jiangsu, P.R. China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"College of Life Science and Pharmaceutics, Nanjing University of Technology, Nanjing, Jiangsu, P.R. China","institution_ids":["https://openalex.org/I134687103"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5107852988","display_name":"Ping Wei","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I134687103","display_name":"Nanjing Tech University","ror":"https://ror.org/03sd35x91","country_code":"CN","type":"education","lineage":["https://openalex.org/I134687103"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Ping Wei","raw_affiliation_strings":["College of Life Science and Pharmaceutics, Nanjing University of Technology, Nanjing, Jiangsu, P.R. China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"College of Life Science and Pharmaceutics, Nanjing University of Technology, Nanjing, Jiangsu, P.R. China","institution_ids":["https://openalex.org/I134687103"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5111801751","display_name":"Qineng Ping","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I161716053","display_name":"China Pharmaceutical University","ror":"https://ror.org/01sfm2718","country_code":"CN","type":"education","lineage":["https://openalex.org/I161716053"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"QiNeng Ping","raw_affiliation_strings":["China Pharmaceutical University, Nanjing, Jiangsu, P.R. China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"China Pharmaceutical University, Nanjing, Jiangsu, P.R. China","institution_ids":["https://openalex.org/I161716053"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":1.5641,"has_fulltext":false,"cited_by_count":70,"citation_normalized_percentile":{"value":0.7948986,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":87,"max":99},"biblio":{"volume":"34","issue":"1","first_page":"107","last_page":"115"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10256","display_name":"Drug Solubulity and Delivery Systems","score":0.4966000020503998,"subfield":{"id":"https://openalex.org/subfields/3003","display_name":"Pharmaceutical Science"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10256","display_name":"Drug Solubulity and Delivery Systems","score":0.4966000020503998,"subfield":{"id":"https://openalex.org/subfields/3003","display_name":"Pharmaceutical Science"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10920","display_name":"Advanced Drug Delivery Systems","score":0.3840000033378601,"subfield":{"id":"https://openalex.org/subfields/3003","display_name":"Pharmaceutical Science"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10063","display_name":"Nanoparticle-Based Drug Delivery","score":0.10490000247955322,"subfield":{"id":"https://openalex.org/subfields/2502","display_name":"Biomaterials"},"field":{"id":"https://openalex.org/fields/25","display_name":"Materials Science"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/plga-nanoparticles","display_name":"PLGA nanoparticles","score":0.9150000214576721},{"id":"https://openalex.org/keywords/5-fluorouracil","display_name":"5-fluorouracil","score":0.9990000128746033},{"id":"https://openalex.org/keywords/oral-drug-delivery","display_name":"oral drug delivery","score":0.9670000076293945},{"id":"https://openalex.org/keywords/high-pressure-homogenization","display_name":"high-pressure homogenization","score":0.8669999837875366},{"id":"https://openalex.org/keywords/emulsion-solvent-evaporation","display_name":"emulsion solvent evaporation","score":0.8690000176429749},{"id":"https://openalex.org/keywords/ammonia-solvents","display_name":"ammonia solvents","score":0.39899998903274536},{"id":"https://openalex.org/keywords/drug-solubility-enhancement","display_name":"drug solubility enhancement","score":0.7269999980926514},{"id":"https://openalex.org/keywords/controlled-drug-release","display_name":"controlled drug release","score":0.7379999756813049},{"id":"https://openalex.org/keywords/oral-bioavailability","display_name":"oral bioavailability","score":0.9470000267028809},{"id":"https://openalex.org/keywords/mean-residence-time","display_name":"mean residence time","score":0.8339999914169312},{"id":"https://openalex.org/keywords/anticancer-drug-delivery","display_name":"anticancer drug delivery","score":0.6790000200271606},{"id":"https://openalex.org/keywords/nanoparticle-characterization","display_name":"nanoparticle characterization","score":0.4449999928474426}],"concepts":[{"id":"https://openalex.org/C181389837","wikidata":"https://www.wikidata.org/wiki/Q461809","display_name":"Bioavailability","level":2,"score":0.840636134147644},{"id":"https://openalex.org/C2780165375","wikidata":"https://www.wikidata.org/wiki/Q2102907","display_name":"PLGA","level":3,"score":0.8226674199104309},{"id":"https://openalex.org/C155574463","wikidata":"https://www.wikidata.org/wiki/Q170731","display_name":"Solubility","level":2,"score":0.6537528038024902},{"id":"https://openalex.org/C187530423","wikidata":"https://www.wikidata.org/wiki/Q7140503","display_name":"Particle size","level":2,"score":0.6536495685577393},{"id":"https://openalex.org/C207001950","wikidata":"https://www.wikidata.org/wiki/Q141124","display_name":"In vivo","level":2,"score":0.6265408992767334},{"id":"https://openalex.org/C155672457","wikidata":"https://www.wikidata.org/wiki/Q61231","display_name":"Nanoparticle","level":2,"score":0.6191274523735046},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.5831618309020996},{"id":"https://openalex.org/C77281830","wikidata":"https://www.wikidata.org/wiki/Q718608","display_name":"Dosage form","level":2,"score":0.46350640058517456},{"id":"https://openalex.org/C2779820397","wikidata":"https://www.wikidata.org/wiki/Q1392806","display_name":"Drug delivery","level":2,"score":0.4386581480503082},{"id":"https://openalex.org/C2778722038","wikidata":"https://www.wikidata.org/wiki/Q17030643","display_name":"Homogenization (climate)","level":3,"score":0.4386161267757416},{"id":"https://openalex.org/C2780471494","wikidata":"https://www.wikidata.org/wiki/Q146505","display_name":"Solvent","level":2,"score":0.4325034022331238},{"id":"https://openalex.org/C43617362","wikidata":"https://www.wikidata.org/wiki/Q170050","display_name":"Chromatography","level":1,"score":0.4210489094257355},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.4115503132343292},{"id":"https://openalex.org/C13965031","wikidata":"https://www.wikidata.org/wiki/Q243545","display_name":"Nuclear chemistry","level":1,"score":0.4060344099998474},{"id":"https://openalex.org/C192562407","wikidata":"https://www.wikidata.org/wiki/Q228736","display_name":"Materials science","level":0,"score":0.3994288444519043},{"id":"https://openalex.org/C42360764","wikidata":"https://www.wikidata.org/wiki/Q83588","display_name":"Chemical engineering","level":1,"score":0.37719985842704773},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.31220144033432007},{"id":"https://openalex.org/C171250308","wikidata":"https://www.wikidata.org/wiki/Q11468","display_name":"Nanotechnology","level":1,"score":0.2685178816318512},{"id":"https://openalex.org/C178790620","wikidata":"https://www.wikidata.org/wiki/Q11351","display_name":"Organic chemistry","level":1,"score":0.21089118719100952},{"id":"https://openalex.org/C147789679","wikidata":"https://www.wikidata.org/wiki/Q11372","display_name":"Physical chemistry","level":1,"score":0.0},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.0},{"id":"https://openalex.org/C127413603","wikidata":"https://www.wikidata.org/wiki/Q11023","display_name":"Engineering","level":0,"score":0.0},{"id":"https://openalex.org/C130217890","wikidata":"https://www.wikidata.org/wiki/Q47041","display_name":"Biodiversity","level":2,"score":0.0},{"id":"https://openalex.org/C18903297","wikidata":"https://www.wikidata.org/wiki/Q7150","display_name":"Ecology","level":1,"score":0.0},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.0},{"id":"https://openalex.org/C150903083","wikidata":"https://www.wikidata.org/wiki/Q7108","display_name":"Biotechnology","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000077182","descriptor_name":"Polylactic Acid-Polyglycolic Acid Copolymer","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000284","descriptor_name":"Administration, Oral","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000964","descriptor_name":"Antimetabolites, Antineoplastic","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D000964","descriptor_name":"Antimetabolites, Antineoplastic","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D000964","descriptor_name":"Antimetabolites, Antineoplastic","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D001682","descriptor_name":"Biological Availability","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003692","descriptor_name":"Delayed-Action Preparations","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004305","descriptor_name":"Dose-Response Relationship, Drug","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004337","descriptor_name":"Drug Carriers","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004655","descriptor_name":"Emulsions","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005472","descriptor_name":"Fluorouracil","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D005472","descriptor_name":"Fluorouracil","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D005472","descriptor_name":"Fluorouracil","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D006207","descriptor_name":"Half-Life","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010316","descriptor_name":"Particle Size","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011100","descriptor_name":"Polyglycolic Acid","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":true},{"descriptor_ui":"D011108","descriptor_name":"Polymers","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":true},{"descriptor_ui":"D012995","descriptor_name":"Solubility","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013678","descriptor_name":"Technology, Pharmaceutical","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":true},{"descriptor_ui":"D017207","descriptor_name":"Rats, Sprague-Dawley","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D019344","descriptor_name":"Lactic Acid","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":true},{"descriptor_ui":"D019540","descriptor_name":"Area Under Curve","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D051381","descriptor_name":"Rats","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D053758","descriptor_name":"Nanoparticles","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1080/03639040701484593","doi":"https://doi.org/10.1080/03639040701484593","is_oa":false,"landing_page_url":"https://doi.org/10.1080/03639040701484593","pdf_url":null,"source":{"id":"https://openalex.org/S162444473","display_name":"Drug Development and Industrial Pharmacy","issn_l":"0363-9045","issn":["0363-9045","1520-5762"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","medline","norway-1","poland-70","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Drug Development and Industrial Pharmacy","raw_type":"journal-article"},{"id":"pmid:18214762","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/18214762","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Drug development and industrial pharmacy","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.9391000270843506}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320322769","display_name":"Natural Science Foundation of Jiangsu Province","ror":"https://ror.org/01h0zpd94"}],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":20,"referenced_works":["https://openalex.org/W1967713688","https://openalex.org/W1984520012","https://openalex.org/W1995082650","https://openalex.org/W1998532938","https://openalex.org/W2009974403","https://openalex.org/W2029330662","https://openalex.org/W2032896288","https://openalex.org/W2035757734","https://openalex.org/W2040344672","https://openalex.org/W2042890088","https://openalex.org/W2050394185","https://openalex.org/W2057312947","https://openalex.org/W2061389108","https://openalex.org/W2063269146","https://openalex.org/W2100633797","https://openalex.org/W2110115130","https://openalex.org/W2118794297","https://openalex.org/W2148628183","https://openalex.org/W2154502028","https://openalex.org/W2169551242"],"related_works":["https://openalex.org/W2387847980","https://openalex.org/W2369480079","https://openalex.org/W4284959218","https://openalex.org/W2384271540","https://openalex.org/W2353158878","https://openalex.org/W2285665565","https://openalex.org/W919107762","https://openalex.org/W2393010110","https://openalex.org/W2807489698","https://openalex.org/W2070588189"],"abstract_inverted_index":{"The":[0,101,163],"objective":[1],"of":[2,28,43,51,69,83,128,155,178,184,208,239,247],"the":[3,9,20,25,33,44,49,54,60,67,81,144,161,203],"present":[4],"study":[5],"was":[6,57,158,167,193,212],"to":[7,18,24,65,73,86,107,133,143,188,222],"incorporate":[8],"hydrophilic":[10],"anti-cancer":[11],"drug":[12,147,226],"5-Fluorouracil(5-FU)":[13],"into":[14],"poly(lactide-co-glycolide)":[15],"(PLGA)":[16],"nanoparticles(NP)":[17],"improve":[19],"oral":[21,175,182,230],"bioavailability.":[22],"Owing":[23],"high":[26],"solubility":[27,68],"5-FU":[29,92,114,129,176,185,197,209,231],"in":[30,117,120,123,160,164,169],"basic":[31],"water,":[32],"water-in-oil-in-water":[34],"(w/o/w)":[35],"emulsification":[36],"process":[37],"has":[38],"been":[39],"chosen":[40],"as":[41,59,77,79,199],"one":[42],"most":[45],"appropriate":[46],"method":[47],"for":[48,229],"encapsulation":[50,115],"5-FU,":[52,156],"and":[53,119,148,245],"ammonia":[55],"solution":[56,198],"used":[58],"inner":[61],"aqueous":[62],"phase":[63],"solvent":[64],"increase":[66],"5-FU.":[70],"In":[71,125],"order":[72],"reach":[74],"submicron":[75],"size":[76,112],"well":[78],"increasing":[80],"grade":[82],"monodispersity":[84],"compared":[85],"previous":[87],"preparation":[88],"techniques,":[89],"we":[90],"prepared":[91],"loaded":[93,186,210],"PLGA-NP":[94,187,211],"by":[95,150,236],"a":[96,151,224],"high-pressure":[97],"emulsification-solvent":[98],"evaporation":[99],"process.":[100],"PLGA-NPs":[102],"were":[103],"characterized":[104],"with":[105,137],"respect":[106],"their":[108],"morphology,":[109],"particle":[110],"size,":[111],"distribution,":[113],"efficiency,":[116],"vitro":[118,126],"vivo":[121,165],"studies":[122],"rats.":[124],"release":[127,141,154],"from":[130],"nanoparticles":[131],"appeared":[132],"have":[134],"two":[135],"components":[136],"an":[138,174],"initial":[139],"rapid":[140],"due":[142],"surface":[145],"associated":[146],"followed":[149],"slower":[152],"exponential":[153],"which":[157,192],"dissolved":[159],"core.":[162],"research":[166],"studied":[168],"male":[170],"Sprague-Dawley":[171],"rats":[172,189],"after":[173],"dose":[177],"45":[179],"mg/kg.":[180],"Single":[181],"administration":[183],"produced":[190],"bioavailability,":[191],"statistically":[194],"higher":[195],"than":[196],"negative":[200],"control.":[201],"And":[202],"MRT":[204],"(mean":[205],"residence":[206],"time)":[207],"significantly":[213],"(P":[214],"<":[215],"0.05)":[216],"modified.":[217],"Thus,":[218],"it":[219],"is":[220],"possible":[221,237],"design":[223],"controlled":[225],"delivery":[227],"system":[228],"delivery,":[232],"improving":[233],"therapy":[234],"efficiency":[235],"reduction":[238,246],"time":[240],"intervals":[241],"between":[242],"peroral":[243],"administrations":[244],"local":[248],"gastrointestinal":[249],"side":[250],"effects.":[251]},"counts_by_year":[{"year":2025,"cited_by_count":4},{"year":2024,"cited_by_count":2},{"year":2023,"cited_by_count":6},{"year":2022,"cited_by_count":2},{"year":2021,"cited_by_count":1},{"year":2020,"cited_by_count":3},{"year":2019,"cited_by_count":4},{"year":2018,"cited_by_count":4},{"year":2017,"cited_by_count":5},{"year":2016,"cited_by_count":5},{"year":2015,"cited_by_count":11},{"year":2014,"cited_by_count":8},{"year":2013,"cited_by_count":4},{"year":2012,"cited_by_count":4}],"updated_date":"2026-11-06T12:05:46.655746","created_date":"2016-06-24T00:00:00"}